EMBO Molecular Medicine

EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance. To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields: Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention). Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease. Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI)

EMBO Molecular Medicine是一本医学-研究与实验领域的开放获取期刊，由Wiley-Blackwell出版。专注于跨学科的临床研究和基础生命科学之间的交叉领域。欢迎提交在细胞和/或动物模型中进行的原创研究，只要它们能够证明对人类疾病的相关性。 为了强化期刊对精准医学的承诺并更清晰地定义方向，编辑部扩大了EMM的研究范围，并邀请以下领域的投稿： 1. 环境健康和医学：特别是环境医学领域的功能和机制方面的研究，包括暴露组研究、毒理学、生物标志物、建模和干预。 2. 临床研究和病例报告：人类临床研究提供了如何控制特定疾病的决定性线索，涵盖流行病学、病理生理学、治疗和疫苗研究。支持该疾病假设的驱动研究的病例报告也是欢迎的。 3. 生物医学技术：提交具有直接转化潜力和适用性的创新材料、工具、设备和技术的研究，涉及成像技术、药物输送系统、组织工程和人工智能。